Connected Health, Boundless Care: Sinocare Showcases at the 58th MEDICA

Release time : 2026-11-19
View count : 64

MEDICA 2026, the 58th World Forum for Medicine, International Trade Fair with Forums and Conferences, takes place from November 16 to 19 at Messe Düsseldorf in Germany. One of the largest and most specialized trade fairs for hospitals and medical equipment in the world, MEDICA this year brings together more than 4,800 exhibitors from about 70 countries along with trade visitors from more than 160 countries and regions. Sinocare is exhibiting its chronic disease testing and management solutions, presenting end-to-end capabilities that run from home monitoring to hospital-wide management.

2747e3d7-102a-4b79-b41a-e7822fa1abf5

At MEDICA 2026, Sinocare presents itself as the leading diabetes digital management expert in the world. What it brings is not a set of standalone products but a continuous pathway through the home, the pharmacy and the hospital, so that screening comes earlier, monitoring becomes routine, diagnosis becomes more accessible and management more continuous. From a fingertip blood glucose reading to hospital-wide data, Sinocare wants to show that the gaps in chronic disease management are being closed, one simpler and more human tool at a time.

 

Bringing Daily Monitoring Closer to the Home

Making monitoring a habit rather than a burden is the first step in chronic disease management. Sinocare's home product line folds blood glucose, blood lipids, uric acid, blood ketone and blood pressure into one daily routine, so a family no longer makes repeated hospital trips for one or two tests. The Safe AQ max Blood Glucose Monitoring System kit returns a reading in seconds from a tiny fingertip sample, and a single KUG-11 Glucose, Uric Acid & Ketone Meter reads glucose, uric acid and blood ketone at once, so people tracking several metabolic indicators can carry fewer devices. Sinocare extends the same care to pets. The GV-100 Veterinary Blood Glucose Monitoring System gives families a dependable way to look after dogs and cats with diabetes at home.

2ecd83c3-db36-4033-895b-9791de45626e

Bringing a “Desktop Lab” to Retail Pharmacies

Whether professional testing can reach primary care decides whether chronic disease screening happens where people live. The iCARE-1300 Portable Automatic Multifunction Analyzer packs tests that normally need a clinical laboratory, among them blood glucose, blood lipids, HbA1c and renal function, into an integrated benchtop workstation the size of a rice cooker. It returns results within 15 minutes and needs no dedicated operator. For retail pharmacies moving from selling medicines to providing health services, that means several indicators can be tested and interpreted in a single store visit, giving a basis for medication advice and health consultation. Precision medicine at the primary care level is no longer a vision. It is already happening.

e51c634f-4649-4cec-8b74-e645dc9842f6

From Risk Screening to Hospital-Wide Glucose Management

In hospitals, Sinocare addresses two persistent gaps: how to find high-risk people who have not yet been diagnosed, and how to bring glucose data scattered across departments into one place. The AGEscan Advanced Glycation End Products Fluorescence Detector requires neither blood draw nor reagent. It scans the crystalline lens of the eye and returns a value in six seconds, turning diabetes risk screening from invasive to non-invasive and making it possible at check-up centers, endocrinology departments and primary care institutions. The Safe AQ 8000 Hospital Blood Glucose Smart Management System gathers bedside test results, supports unified review of hospital-wide glucose data with alerts for abnormal values, and works with immediate bedside report printing, so outpatient screening and ward monitoring end up in the same system. When screening and inpatient management are genuinely connected, diabetes management can finally close the loop.

0e832db0-5028-4ca1-aa64-d7ae05eaae02

Europe is one of the earliest markets in Sinocare's international expansion. In 2007, Sinocare passed ISO 13485 certification with Germany's TÜV and obtained the EU CE certificate, and its products have since entered retail and professional channels in many European countries. During MEDICA 2026, the Sinocare team is meeting customers and partners from around the world at its booth to discuss how chronic disease testing and management solutions can be adapted for Europe and for other markets.

Founded in 2002, Sinocare is China's largest diabetes management company and ranks first worldwide in blood glucose meter sales. With biosensing technology at its core, its business covers home chronic disease testing, professional institutional testing and digital diabetes management. Its products and services reach 187 countries and regions and serve more than 25 million users. From the home to the hospital, and from human health to pet health, Sinocare is turning its “Biosensing + AI + Healthcare” capabilities, step by step, into health management that reaches into daily life. Looking ahead, the company will combine AI agents, chronic disease expertise in areas such as diabetes, and long-term behavior management to build capabilities that stay with users over time, turning advanced technology into a real force for better health and exploring the future of intelligent health together with partners worldwide.